COMPASS Pathways (CMPS) News Today $4.66 -0.10 (-2.10%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period COMPASS Pathways plc (NASDAQ:CMPS) Short Interest Down 6.2% in OctoberCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) was the target of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 5,450,000 shares, a drop of 6.2% from the October 15th total of 5,810,000 shares. Based on an average daily volume of 751,300 shares, the short-interest ratio is presently 7.3 days.November 18 at 10:12 AM | marketbeat.comCompass Pathways to participate in Stifel 2024 Healthcare ConferenceNovember 14, 2024 | globenewswire.comStrategic Opportunity in COMPASS Pathways Amid Extended Phase 3 Trials and Conservative Price TargetNovember 11, 2024 | markets.businessinsider.comARK Investment Management LLC Sells 95,386 Shares of COMPASS Pathways plc (NASDAQ:CMPS)ARK Investment Management LLC lessened its stake in shares of COMPASS Pathways plc (NASDAQ:CMPS - Free Report) by 4.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,005,125 shares of the company's stock after selling 95,386 shares during the perioNovember 8, 2024 | marketbeat.comBTIG Keeps Their Buy Rating on COMPASS Pathways (CMPS)November 5, 2024 | markets.businessinsider.comVikram Purohit Recommends ‘Buy’ for COMPASS Pathways Amid Strategic Adjustments and Promising COMP360 ProgramNovember 4, 2024 | markets.businessinsider.comCompass Pathways: Phase 3 Trial Delay - Both Understandable And DisappointingNovember 4, 2024 | seekingalpha.comCOMPASS Pathways (NASDAQ:CMPS) Issues Quarterly Earnings ResultsCOMPASS Pathways (NASDAQ:CMPS - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.60) by $0.04. During the same quarter last year, the firm posted ($0.67) earnings per share.November 3, 2024 | marketbeat.comCompass Pathways cuts 30% of workforce on Phase 3 trial delaysNovember 2, 2024 | finance.yahoo.comCompass Pathways Focuses on Key Psilocybin ProgramNovember 2, 2024 | markets.businessinsider.comCOMPASS Pathways plc (NASDAQ:CMPS) Q3 2024 Earnings Call TranscriptNovember 2, 2024 | msn.comCompass Pathways PLC (CMPS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...November 2, 2024 | finance.yahoo.comCompass Pathways price target lowered to $60 from $120 at H.C. WainwrightNovember 2, 2024 | markets.businessinsider.comCompass Pathways price target lowered to $18 from $23 at RBC CapitalNovember 2, 2024 | markets.businessinsider.comHC Wainwright Has Lowered Expectations for COMPASS Pathways (NASDAQ:CMPS) Stock PriceHC Wainwright cut their target price on shares of COMPASS Pathways from $120.00 to $60.00 and set a "buy" rating for the company in a research report on Friday.November 1, 2024 | marketbeat.comCompass Pathways Plc (CMPS) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | msn.comCompass Pathways sees 2024 operating net cash use $114M-$120MOctober 31, 2024 | markets.businessinsider.comCompass Pathways' Losses Widen in Q3October 31, 2024 | fool.comAs Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve CashOctober 31, 2024 | benzinga.comRising High: Compass Pathways reports Q3 earningsOctober 31, 2024 | markets.businessinsider.comUncovering Potential: Compass Pathways's Earnings PreviewOctober 31, 2024 | benzinga.comCOMPASS Pathways ADS Q3 2024 Earnings PreviewOctober 30, 2024 | msn.comCOMPASS Pathways (CMPS) Set to Announce Earnings on ThursdayCOMPASS Pathways (NASDAQ:CMPS) will be releasing earnings before the market opens on Thursday, October 31, Zacks reports.October 25, 2024 | marketbeat.comCompass Pathways to Announce Third Quarter Financial Results on October 31, 2024October 24, 2024 | businesswire.comCOMPASS Pathways plc (NASDAQ:CMPS) Short Interest UpdateCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 6,390,000 shares, an increase of 8.9% from the September 15th total of 5,870,000 shares. Based on an average daily trading volume, of 516,300 shares, the days-to-cover ratio is currently 12.4 days.October 17, 2024 | marketbeat.comCompass Pathways (NASDAQ:CMPS) Stock Quotes, Forecast and News SummaryOctober 17, 2024 | benzinga.comCOMPASS Pathways plc (NASDAQ:CMPS) Given Consensus Recommendation of "Buy" by BrokeragesCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) has been given an average rating of "Buy" by the six analysts that are covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have covOctober 6, 2024 | marketbeat.comRenaissance Technologies LLC Grows Stake in COMPASS Pathways plc (NASDAQ:CMPS)Renaissance Technologies LLC boosted its holdings in shares of COMPASS Pathways plc (NASDAQ:CMPS - Free Report) by 1,518.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 263,800 shares of the company's stock after puOctober 4, 2024 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells $16,093,000.00 in StockSeptember 28, 2024 | insidertrades.comLife Sciences N.V. Atai Sells 2,660,000 Shares of COMPASS Pathways plc (NASDAQ:CMPS) StockCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) major shareholder Life Sciences N.V. Atai sold 2,660,000 shares of the company's stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $6.05, for a total transaction of $16,093,000.00. Following the completion of the sale, the insider now directly owns 6,905,774 shares of the company's stock, valued at $41,779,932.70. The sale was disclosed in a filing with the SEC, which is accessible through this link. Large shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.September 27, 2024 | marketbeat.comAffinity Asset Advisors LLC Cuts Stock Holdings in COMPASS Pathways plc (NASDAQ:CMPS)Affinity Asset Advisors LLC reduced its stake in COMPASS Pathways plc (NASDAQ:CMPS - Free Report) by 51.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 500,512 shares of the companySeptember 25, 2024 | marketbeat.comLogos Global Management LP Raises Stake in COMPASS Pathways plc (NASDAQ:CMPS)Logos Global Management LP increased its position in COMPASS Pathways plc (NASDAQ:CMPS - Free Report) by 349.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,159,030 shares of the company's stocSeptember 24, 2024 | marketbeat.comBuy Rating Affirmed for COMPASS Pathways Amid Promising Psilocybin Treatment Prospects and Strategic Market PositioningSeptember 18, 2024 | markets.businessinsider.comCOMPASS Pathways plc (NASDAQ:CMPS) Sees Large Growth in Short InterestCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 5,600,000 shares, a growth of 19.7% from the August 15th total of 4,680,000 shares. Based on an average daily trading volume, of 439,200 shares, the days-to-cover ratio is currently 12.8 days.September 15, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Trading Up 8%COMPASS Pathways (NASDAQ:CMPS) Trading Up 8%September 13, 2024 | marketbeat.comRBC Capital Remains a Buy on COMPASS Pathways (CMPS)September 11, 2024 | markets.businessinsider.comCOMPASS Pathways plc (NASDAQ:CMPS) Given Average Recommendation of "Buy" by BrokeragesShares of COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) have been given a consensus recommendation of "Buy" by the six ratings firms that are currently covering the firm, Marketbeat reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among analSeptember 11, 2024 | marketbeat.comCOMPASS Pathways' (CMPS) "Outperform" Rating Reaffirmed at Royal Bank of CanadaRoyal Bank of Canada reaffirmed an "outperform" rating and set a $23.00 price target on shares of COMPASS Pathways in a research note on Tuesday.September 10, 2024 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Earns Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating on shares of COMPASS Pathways in a research report on Monday.September 9, 2024 | marketbeat.comCompass Pathways to participate in three investor conferences in SeptemberAugust 28, 2024 | globenewswire.comCOMPASS Pathways (NASDAQ:CMPS) Shares Gap Up to $7.19COMPASS Pathways (NASDAQ:CMPS) Shares Gap Up to $7.19August 26, 2024 | marketbeat.comFY2027 Earnings Forecast for COMPASS Pathways plc (NASDAQ:CMPS) Issued By HC WainwrightCOMPASS Pathways plc (NASDAQ:CMPS - Free Report) - Research analysts at HC Wainwright increased their FY2027 earnings per share (EPS) estimates for COMPASS Pathways in a research report issued on Friday, August 23rd. HC Wainwright analyst P. Trucchio now expects that the company will post earningAugust 26, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for COMPASS Pathways (NASDAQ:CMPS)HC Wainwright restated a "buy" rating and set a $120.00 target price on shares of COMPASS Pathways in a research report on Friday.August 23, 2024 | marketbeat.com109,989 Shares in COMPASS Pathways plc (NASDAQ:CMPS) Bought by Hennion & Walsh Asset Management Inc.Hennion & Walsh Asset Management Inc. purchased a new position in COMPASS Pathways plc (NASDAQ:CMPS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 109,989 shares of the company's stock, valued at approximately $664,000. Hennion & WalsAugust 21, 2024 | marketbeat.comShort Interest in COMPASS Pathways plc (NASDAQ:CMPS) Drops By 11.9%COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) saw a large decrease in short interest in July. As of July 31st, there was short interest totalling 3,850,000 shares, a decrease of 11.9% from the July 15th total of 4,370,000 shares. Based on an average daily trading volume, of 415,500 shares, the days-to-cover ratio is presently 9.3 days.August 19, 2024 | marketbeat.comCOMPASS Pathways to participate in Canaccord Genuity 44th Annual Growth ConferenceAugust 6, 2024 | finance.yahoo.comCOMPASS Pathways (NASDAQ:CMPS) Releases Earnings Results, Misses Expectations By $0.03 EPSCOMPASS Pathways (NASDAQ:CMPS - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.53) by ($0.03). During the same quarter in the previous year, the company posted ($0.62) earnings per share.August 4, 2024 | marketbeat.comRBC Capital Reaffirms Their Buy Rating on COMPASS Pathways (CMPS)August 2, 2024 | markets.businessinsider.comCOMPASS Pathways Poised for Growth with Strong Financials and Strategic Psychedelic Program AdvancementsAugust 2, 2024 | markets.businessinsider.comCOMPASS Pathways (NASDAQ:CMPS) Price Target Cut to $48.00Canaccord Genuity Group reduced their price objective on shares of COMPASS Pathways from $50.00 to $48.00 and set a "buy" rating for the company in a research note on Friday.August 2, 2024 | marketbeat.com Get COMPASS Pathways News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin CMPS Media Mentions By Week CMPS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMPS News Sentiment▼0.950.45▲Average Medical News Sentiment CMPS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMPS Articles This Week▼33▲CMPS Articles Average Week Get COMPASS Pathways News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SAGE News Today MGNX News Today RPTX News Today KURA News Today MESO News Today GYRE News Today RCKT News Today CALT News Today ARQT News Today ANIP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMPS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding COMPASS Pathways plc Please log in to your account or sign up in order to add this asset to your watchlist. Share COMPASS Pathways With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
